8.18MMarket Cap-547P/E (TTM)
0.1842High0.1701Low386.31KVolume0.1800Open0.1778Pre Close67.99KTurnover1.48%Turnover RatioLossP/E (Static)46.66MShares1.205052wk High-0.93P/B4.57MFloat Cap0.111252wk Low--Dividend TTM26.09MShs Float7.3500Historical High--Div YieldTTM7.93%Amplitude0.1112Historical Low0.1750Avg Price1Lot Size
NLS Pharmaceutics Stock Forum
By Denny Jacob
NLS Pharmaceutics and Kadimastem entered a binding term sheet to merge in which the latter business will become a subsidiary of the former company.
The combined company, which remains subject to shareholder approval from both sides, is expected to operate under the name Kadimastem and be traded on the Nasdaq Capital Market. Existing Kadimastem shareholders will hold 85% of t...
down to 600
No comment yet